Daraxonrasib
Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Daraxonrasib
Trade Name
Synonyms RMC 6236|RMC6236|RMC-6236
Drug Descriptions

Daraxonrasib (RMC-6236) forms a binary complex with CypA, which prevents GTP-bound RAS from interacting with downstream effectors, potentially leading to anti-tumor activity (Cancer Res 2022;82(12_Suppl): Abstract nr 3597, PMID: 38593348).

DrugClasses RAS Inhibitor (Pan) 13
CAS Registry Number 2765081-21-6
NCIT ID C188048

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AMG193 + Daraxonrasib AMG193 Daraxonrasib 0 1
Azenosertib + Daraxonrasib Azenosertib Daraxonrasib 0 0
Bevacizumab + Daraxonrasib + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin Bevacizumab Daraxonrasib Fluorouracil Irinotecan Leucovorin Oxaliplatin 0 1
Bevacizumab + Daraxonrasib + Fluorouracil + Leucovorin + Oxaliplatin Bevacizumab Daraxonrasib Fluorouracil Leucovorin Oxaliplatin 0 1
Carboplatin + Daraxonrasib + Pembrolizumab + Pemetrexed Disodium Carboplatin Daraxonrasib Pembrolizumab Pemetrexed Disodium 0 1
Carboplatin + Daraxonrasib + Pembrolizumab + Pemetrexed Disodium + RMC-6291 Carboplatin Daraxonrasib Pembrolizumab Pemetrexed Disodium RMC-6291 0 1
Carboplatin + Daraxonrasib + Pemetrexed Disodium + RMC-9805 Carboplatin Daraxonrasib Pemetrexed Disodium RMC-9805 0 1
Cetuximab + Daraxonrasib Cetuximab Daraxonrasib 0 1
Cetuximab + Daraxonrasib + Fluorouracil + Leucovorin + Oxaliplatin Cetuximab Daraxonrasib Fluorouracil Leucovorin Oxaliplatin 0 1
Cisplatin + Daraxonrasib + Pembrolizumab + Pemetrexed Disodium Cisplatin Daraxonrasib Pembrolizumab Pemetrexed Disodium 0 1
Cisplatin + Daraxonrasib + Pembrolizumab + Pemetrexed Disodium + RMC-6291 Cisplatin Daraxonrasib Pembrolizumab Pemetrexed Disodium RMC-6291 0 1
Cisplatin + Daraxonrasib + Pemetrexed Disodium + RMC-9805 Cisplatin Daraxonrasib Pemetrexed Disodium RMC-9805 0 1
Daraxonrasib Daraxonrasib 0 4
Daraxonrasib + Gemcitabine + Nab-paclitaxel Daraxonrasib Gemcitabine Nab-paclitaxel 0 1
Daraxonrasib + HRX-0233 Daraxonrasib HRX-0233 0 0
Daraxonrasib + Pembrolizumab Daraxonrasib Pembrolizumab 0 1
Daraxonrasib + Pembrolizumab + RMC-6291 Daraxonrasib Pembrolizumab RMC-6291 0 1
Daraxonrasib + Pembrolizumab + RMC-9805 Daraxonrasib Pembrolizumab RMC-9805 0 1
Daraxonrasib + RMC-6291 Daraxonrasib RMC-6291 0 1
Daraxonrasib + TNG462 Daraxonrasib TNG462 0 1
Daraxonrasib + unspecified PD-1 antibody Daraxonrasib unspecified PD-1 antibody 0 0


Additional content available in Icon for CKB-BoostCKB BOOST